Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review.
about
New Immunotherapy Strategies in Breast Cancer.The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model.A functional SNP in the 3'-UTR of TAP2 gene interacts with microRNA hsa-miR-1270 to suppress the gene expression.
P2860
Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Are pharmacogenomic biomarkers ...... r patients? Literature review.
@en
type
label
Are pharmacogenomic biomarkers ...... r patients? Literature review.
@en
prefLabel
Are pharmacogenomic biomarkers ...... r patients? Literature review.
@en
P2093
P2860
P1476
Are pharmacogenomic biomarkers ...... r patients? Literature review.
@en
P2093
Francesca De Iuliis
Gerardo Salerno
Susanna Scarpa
P2860
P2888
P304
P356
10.1007/S00280-015-2818-4
P577
2015-07-22T00:00:00Z
P6179
1026409783